journal article·2024-09

Potential antifungal applications of heterometallic silica nanohybrids: A synergistic activity

Piumika Yapa, Imalka Munaweera, Manjula M. Weerasekera, Laksiri Weerasinghe, Chanaka Sandaruwan

Publisher page

Abstract

An estimated 1.7 million fatalities and 150 million cases worldwide are attributed to fungal infections annually, that are in rise due to immunocompromised patient population. The challenges posed by traditional treatments can be addressed with the help of nanotechnology advancements. In this study, Co, Cu, and Ag-were doped into silica nanoparticles. Then the synthesized monometallic silica nanohybrids were combined to formulate heterometallic silica nanohybrids, characterized structurally and morphologically, compared, and evaluated for antifungal activity based on their individual and synergistic activity. The antifungal assays were conducted by using ATCC cultures of Candida albicans and QC samples of Trichophyton rubrum, Microsporum gypseum, and Aspergillus niger. The MIC (ranging from 49.00 to 1560.00 μg/mL), MFC (ranging from 197.00 to 3125.00 μg/mL), IC50 values (ranging from 31.10 to 400.80 μg/mL), and FICI of nanohybrids were determined and compared. Moreover, well diffusion assay was performed. ABTS assay and DPPH assay were conducted to investigate the radical scavenging activity (RSA) of nanohybrids. SEM analysis clearly evidenced the structural deformations of each fungal cells and spores due to the treatment with trimetallic nanohybrid. According to the results, the trimetallic silica nanohybrids exhibited the most powerful synergistic RSA and the most effective antifungal activity, compared to the bimetallic silica nanohybrids.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Nanocomposite Films for Food Packaging · Antifungal resistance and susceptibility

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Global and multi-national prevalence of fungal diseases—estimate precision10.3390/jof3040057 ↗
2. Antifungal drugs10.3390/metabo10030106 ↗
3. Chapter 3 - fungal infections
4. The changing epidemiology of invasive fungal infections10.1007/978-1-4939-6515-1_2 ↗
5. Emerging fungal infections: new patients, new patterns, and new pathogens10.3390/jof5030067 ↗
6. The global problem of antifungal resistance: prevalence, mechanisms, and management10.1016/S1473-3099(17)30316-X ↗
7. Infections due to emerging and uncommon medically important fungal pathogens10.1111/j.1470-9465.2004.00839.x ↗
8. Emerging threats in antifungal-resistant fungal pathogens
9. Epidemiology and risk factors for invasive candidiasis
10. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)10.1016/j.ijantimicag.2011.02.016 ↗
11. Trends in the epidemiology of invasive fungal infections10.3314/jjmm.48.1 ↗
12. Hidden killers: human fungal infections
13. The dermatophytes10.1128/CMR.8.2.240 ↗
14. Dermatophytes and dermatophytosis
15. Exposure and health effects of fungi on humans10.1016/j.jaip.2016.01.008 ↗
16. CDC.gov. [cited 2023 Dec 31]. Available from: https://www.cdc.gov/drugresistance/pdf/threatsreport/2019-ar-threats-report-508.pdf.
17. WHO.int. [cited 2023 Dec 31]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-.
18. Nonalbicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India
19. Treatment alternatives for multidrug-resistant fungal pathogens
20. Development and research progress of anti-drug resistant fungal drugs10.1016/j.jiph.2022.08.004 ↗
21. Applications of nanotechnology in medical field: a brief review10.1016/j.glohj.2023.02.008 ↗
22. Synthesis and structural characterization of copper nanoparticles doped activated carbon derived from coconut coir for drinking water purification
23. A comprehensive review on electrospun nanohybrid membranes for wastewater treatment10.3762/bjnano.13.10 ↗
24. Metal nanoparticles as therapeutic agents: a paradigm shift in medicine
25. Metal-based nanoparticles as antimicrobial agents: an overview10.3390/nano10020292 ↗
26. Metal nanoparticles: understanding the mechanisms behind antibacterial activity10.1186/s12951-017-0308-z ↗
27. Antifungal activity of silver nanoparticles obtained by green synthesis10.1590/S0036-46652015000200011 ↗
28. Nami · 2021
29. Die Fairness Opinion in der aktien- und übernahmerechtlichen Praxis
30. Contemporary, multidisciplinary roles of mesoporous silica nanohybrids/nanocomposites10.1002/slct.202200574 ↗
31. Chemoradiotherapeutic wrinkled mesoporous silica nanoparticles for use in cancer therapy10.1063/1.4899118 ↗
32. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation
33. Antifungal drug repurposing10.3390/antibiotics9110812 ↗
34. Antifungal therapy in fungal necrotizing soft tissue infections10.1016/j.jss.2020.06.013 ↗
35. Metal doped silica nanohybrids with extensive bacterial coverage for antibacterial applications exhibit synergistic activity10.1016/j.bioadv.2023.213753 ↗
36. The antibacterial mechanism of silver nanoparticles and its application in dentistry10.2147/IJN.S246764 ↗
37. Copper as an antimicrobial agent: recent advances10.1039/D1RA02149D ↗
38. Mesoporous silica particles as drug delivery systems—the state of the art in loading methods and the recent progress in analytical techniques for monitoring these processes10.3390/pharmaceutics13070950 ↗
39. Electrospun polymer materials with fungicidal activity: a review10.3390/molecules27175738 ↗
40. Review on antifungal agents10.52711/0975-4377.2022.00005 ↗
41. Novel modes of antifungal drug administration10.1517/13543784.13.8.903 ↗
42. Synthesis and application of metal doped silica particles for adsorptive desulphurization of fuels10.4491/eer.2014.017 ↗
43. Synthesis of nano-sized mesoporous silicas with metal incorporation10.1016/j.cattod.2004.06.140 ↗
44. Munaweera · 2023
45. Munaweera · 2023
46. Band-gap energy estimation from diffuse reflectance measurements on sol–gel and commercial TiO2: a comparative study10.1007/s10971-011-2582-9 ↗
47. Fabrication of TiO2/WO3 composite nanofibers by electrospinning and photocatalystic performance of the resultant fabrics10.1021/acs.iecr.5b03578 ↗
48. Comparative study of three digestion methods for elemental analysis in traditional medicine products using atomic absorption spectrometry10.1186/s40543-016-0085-6 ↗
49. Weinston
50. Clsi.org. [cited 2024 Mar 6]. Available from: https://clsi.org/media/osthhxax/m27m44sed3e_sample.pdf.
51. M38Ed3 Filamentous Fungi Antifungal Susceptibility Test [Internet]. Clinical & Laboratory Standards Institute. [cited 2024 Mar 6]. Available from: https://clsi.org/standards/products/microbiology/documents/m38/.
52. Clioquinol, an alternative antimicrobial agent against common pathogenic microbe10.1016/j.mycmed.2018.03.007 ↗
53. Synthesis and in vitro and in silico antimicrobial studies of novel piperine–pyridine analogs10.1007/s11164-018-3324-1 ↗
54. The fractional inhibitory concentration (FIC) index as a measure of synergy10.1093/jac/11.5.427 ↗
55. Synergistic activity between Triphala and selected antibiotics against drug resistant clinical isolates10.1186/s12906-019-2618-1 ↗
56. Free-radical scavenging activity properties of ZnO sub-micron particles: size effect and kinetics10.1016/j.jmrt.2021.05.050 ↗
57. Comparison of ABTS/DPPH assays to measure antioxidant capacity in popular antioxidant-rich US foods10.1016/j.jfca.2011.01.008 ↗
58. Antioxidant activity applying an improved ABTS radical cation decolorization assay10.1016/S0891-5849(98)00315-3 ↗
59. Metal nanoparticles as novel antifungal agents for sustainable agriculture: current advances and future directions10.3390/jof7121033 ↗
60. Size and shape dependant antifungal activity of gold nanoparticles: a case study of Candida10.1016/j.colsurfb.2012.06.005 ↗
61. Antifungal activity of zinc oxide nanoparticles against Botrytis cinerea and Penicillium expansum10.1016/j.micres.2010.03.003 ↗
62. Effects of a nanoparticulate silica substrate on cell attachment of Candida albicans10.1111/j.1365-2672.2006.03124.x ↗
63. Unexpected insights into antibacterial activity of zinc oxide nanoparticles against methicillin resistant Staphylococcus aureus (MRSA)10.1039/C7NR08499D ↗
64. Metal nanoparticles for diagnosis and therapy of bacterial infection10.1002/adhm.201701392 ↗
65. Graphene-mediated surface enhanced Raman scattering in silica mesoporous nanocomposite films10.1039/C4CP03582H ↗
66. Multifunctional silver nanoparticle-doped silica for solid-phase extraction and surface-enhanced Raman scattering detection10.1007/s11051-016-3661-1 ↗
67. Glycine adsorption onto DLC and N-DLC thin films studied by XPS and AFM10.1380/ejssnt.2009.217 ↗
68. Understanding chemical versus electrostatic shifts in X-ray photoelectron spectra of organic self-assembled monolayers10.1021/acs.jpcc.5b12387 ↗
69. Tuning the oxidation states of dopants: a strategy for the modulation of material photoluminescence properties
70. Tuning the oxidation states of dopants: a strategy for the modulation of material photoluminescence properties10.1002/chem.202003074 ↗
71. Borophosphate glass as an active media for CuO nanoparticle growth: an efficient catalyst for selenylation of oxadiazoles and application in redox reactions10.1038/s41598-020-72129-w ↗
72. Synthesis and characterization of cobalt-doped SiO2 nanoparticles10.1016/j.physb.2019.07.044 ↗
73. XPS characterisation of core–shell silica–polymer composite particles synthesised by atom transfer radical polymerisation in aqueous media10.1016/j.eurpolymj.2004.02.013 ↗
74. XPS and thermal studies of silver doped SiO2 matrices for plasmonic applications
75. XPS study of the Cu@Cu2O core-shell nanoparticles10.1016/j.apsusc.2008.08.110 ↗
76. Synthesis and characterization of cobalt-doped SiO2 nanoparticles10.1016/j.physb.2019.07.044 ↗
77. The FICI paradigm: correcting flaws in antimicrobial in vitro synergy screens at their inception10.1016/j.bcp.2019.03.001 ↗
78. Synergism of the combination of traditional antibiotics and novel phenolic compounds against Escherichia coli
79. What are fungal infections?
80. The hidden quality gap in discovery10.1016/j.drudis.2013.01.005 ↗
81. Synergistic antimicrobial activity of essential oils and oleoresins of cinnamon (Cinnamomum zeylanicum), clove bud (Syzygium aromaticum) and ginger (Zingiber officinale)
82. In vitro evaluation of antibacterial activity of copper and sulfur nanoparticles for controlling bacterial blight caused by Xanthomonas sp. in Anthurium andraeanum Lind10.4038/sjhs.v3i1.50 ↗
83. Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria10.1016/j.drup.2016.06.002 ↗
84. Recent progress in visible-light active (VLA) TiO2 nano-structures for enhanced photocatalytic activity (PCA) and antibacterial properties: a review
85. A review on recent developments in structural modification of TiO2 for food packaging applications
86. Agar well diffusion assay testing of bacterial susceptibility to various antimicrobials in concentrations non-toxic for human cells in culture10.1016/0305-4179(94)90035-3 ↗
87. Green synthesis of silver nanoparticles: advantages of the yeast Saccharomyces cerevisiae model10.18869/acadpub.cmm.1.3.17 ↗
88. Antifungal properties of zinc oxide nanoparticles on Candida albicans10.3390/coatings12121864 ↗
89. Candida infection in oral leukoplakia: an unperceived public health problem10.1080/00016357.2016.1220018 ↗
90. Slow release anti-fungal skin formulations based on citric acid intercalated layered double hydroxides nanohybrids10.1186/s13065-015-0106-3 ↗
91. Aspergillus species: an emerging pathogen in onychomycosis among diabetics
92. Type 2 diabetes mellitus and oral Candida colonization: analysis of risk factors in a Sri Lankan cohort10.1080/00016357.2019.1607547 ↗
93. Use of denaturing gradient gel electrophoresis for the identification of mixed oral yeasts in human saliva10.1099/jmm.0.050237-0 ↗
94. Easy one-pot low-temperature synthesized Ag-ZnO nanoparticles and their activity against clinical isolates of methicillin-resistant Staphylococcus aureus10.3389/fbioe.2020.00216 ↗
95. Munaweera · 2024
96. Size and shape dependant antifungal activity of gold nanoparticles: a case study of Candida10.1016/j.colsurfb.2012.06.005 ↗
97. Antifungal activity of zinc oxide nanoparticles against Botrytis cinerea and Penicillium expansum10.1016/j.micres.2010.03.003 ↗
98. Effects of a nanoparticulate silica substrate on cell attachment of Candida albicans10.1111/j.1365-2672.2006.03124.x ↗
99. Amphotericin B-silver hybrid nanoparticles: synthesis, properties and antifungal activity10.1016/j.nano.2015.12.378 ↗
100. Green synthesis of zinc oxide nanoparticles using flower extract of Nyctanthes arbor-tristis and their antifungal activity10.1016/j.jksus.2016.10.002 ↗